Is second-line anti-tuberculosis drug susceptibility testing reliable?

被引:1
|
作者
Kim, SJ [1 ]
Espinal, MA
Abe, C
Bai, GH
Boulahbals, F
Fattorinit, L
Gilpin, C
Hoffner, S
Kam, KM
Martin-Casabona, N
Rigouts, L
Vincent, V
机构
[1] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland
[2] Japan Anti TB Assoc, Res Inst TB, Tokyo, Japan
[3] Korea Natl TB Assoc, Korean Inst TB, Seoul, South Korea
[4] Inst Pasteur Algerie Alger, Lab TB, Algiers, Algeria
[5] Inst Super San Lab Bacteriol & Med Mycol, Rome, Italy
[6] Prince Charles Hosp, Queensland Mycobacterium Reference Lab, Brisbane, Qld 4032, Australia
[7] Swedish Inst Infect Dis Control, Solna, Sweden
[8] Dept Hlth, TB Reference Lab, Hong Kong, Hong Kong, Peoples R China
[9] Ciudad Sanitaria & Univ Vall Hebron, Serv Microbiol Hosp, E-08035 Barcelona, Spain
[10] Inst Trop Med, Mycobacteriol Unit, Dept Microbiol, B-2000 Antwerp, Belgium
[11] Inst Pasteur, Ctr Natl Reference Mycobacteries, Paris, France
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:1157 / 1158
页数:2
相关论文
共 50 条
  • [31] Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain
    Shishido, Y.
    Mitarai, S.
    Otomo, K.
    Seki, M.
    Sato, A.
    Yano, I.
    Koyama, A.
    Hattori, T.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (12) : 1334 - 1338
  • [32] Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay
    Trollip, A. P.
    Moore, D.
    Coronel, J.
    Caviedes, L.
    Klages, S.
    Victor, T.
    Romancenco, E.
    Crudu, V.
    Ajbani, K.
    Vineet, V. P.
    Rodrigues, C.
    Jackson, R. L.
    Eisenach, K.
    Garfein, R. S.
    Rodwell, T. C.
    Desmond, E.
    Groessl, E. J.
    Ganiats, T. G.
    Catanzaro, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (02) : 227 - 232
  • [33] Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing
    Achar, Jay
    Seddon, James A.
    Knight, Gwenan M.
    Dodd, Peter J.
    Esmail, Hanif
    Hughes, Jennifer
    Mcquaid, C. Finn
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (05)
  • [34] Multicenter Evaluation of Bactec MGIT 960 System for Second-Line Drug Susceptibility Testing of Mycobacterium tuberculosis Complex
    Lin, S. -Y. Grace
    Desmond, Edward
    Bonato, Donald
    Gross, Wendy
    Siddiqi, Salman
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (11) : 3630 - 3634
  • [35] Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System
    Rodrigues, C.
    Jani, J.
    Shenai, S.
    Thakkar, P.
    Siddiqi, S.
    Mehta, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (12) : 1449 - 1455
  • [36] The diagnostic accuracy of the GenoType® MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs
    Theron, Grant
    Peter, Jonny
    Richardson, Marty
    Barnard, Marinus
    Donegan, Sarah
    Warren, Rob
    Steingart, Karen R.
    Dheda, Keertan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [37] Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort
    Carroll, M. W.
    Lee, M.
    Cai, Y.
    Hallahan, C. W.
    Shaw, P. A.
    Min, J. H.
    Goldfeder, L. C.
    Alekseyev, V.
    Grinkrug, S.
    Kang, H. S.
    Hwang, S.
    Park, H-M.
    Kang, E.
    Lee, S-Y.
    Jin, B.
    Park, H-E.
    Min, S.
    Park, S. K.
    Jeon, D. S.
    Via, L. E.
    Barry, C. E., III
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (07) : 961 - 966
  • [38] How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?
    Ngo, Tien Thuy
    Lau, Charis
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [39] Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs
    Leung, K. L.
    Yip, C. W.
    Yeung, Y. L.
    Wong, K. L.
    Chan, W. Y.
    Chan, M. Y.
    Kam, K. M.
    JOURNAL OF APPLIED MICROBIOLOGY, 2010, 109 (06) : 2087 - 2094
  • [40] Diagnostic accuracy of direct drug susceptibility testing of second-line antitubercular drugs
    Srivastava, Kartiki
    Singh, Varsha
    Raikwar, Vinod Kumar
    Anupurba, Shampa
    MICROBIOLOGY SPECTRUM, 2025,